Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China flag China · Delayed Price · Currency is CNY
8.80
-0.01 (-0.11%)
Aug 28, 2025, 9:45 AM CST

SHE:300158 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
Operating Revenue
2,8982,9483,6073,6655,0284,778
Upgrade
Other Revenue
23.623.619.3763.9866.169.71
Upgrade
2,9212,9713,6263,7295,0944,848
Upgrade
Revenue Growth (YoY)
-8.70%-18.06%-2.75%-26.80%5.07%10.21%
Upgrade
Cost of Revenue
1,7641,8121,8301,8942,0581,825
Upgrade
Gross Profit
1,1581,1591,7961,8343,0363,023
Upgrade
Selling, General & Admin
1,4451,4411,7621,8082,6622,547
Upgrade
Research & Development
325.91349.79189.43178.11218.73136.19
Upgrade
Other Operating Expenses
16.317.79-34.98-22.6415.0157.62
Upgrade
Operating Expenses
1,7691,7931,8961,9492,8872,770
Upgrade
Operating Income
-611.56-634.14-99.52-114.52148.84253.13
Upgrade
Interest Expense
-3.12-3.9-1.21-13.78-19.63-20.85
Upgrade
Interest & Investment Income
23.2447.6454.6760.72,95917.02
Upgrade
Currency Exchange Gain (Loss)
-0.13-0.1300-0.01
Upgrade
Other Non Operating Income (Expenses)
-4.5-2.55-11.0728.7-20.72-1.93
Upgrade
EBT Excluding Unusual Items
-596.06-593.08-57.12-38.93,068247.38
Upgrade
Impairment of Goodwill
-24.74-24.74---0.49-
Upgrade
Gain (Loss) on Sale of Investments
-144.99-139.441.9611.590.830.01
Upgrade
Gain (Loss) on Sale of Assets
-1.0810.540-0.86-0.49-10.73
Upgrade
Asset Writedown
-18.47-18.77-7.62-0.94-13.15-0.02
Upgrade
Other Unusual Items
-549.54-549.5425.0923.8461.6286.22
Upgrade
Pretax Income
-1,335-1,315-37.69-5.283,116322.86
Upgrade
Income Tax Expense
19.6717.9210.1851.72506.4969.29
Upgrade
Earnings From Continuing Operations
-1,355-1,333-47.87-572,610253.57
Upgrade
Minority Interest in Earnings
3.254.383.895.717.88.45
Upgrade
Net Income
-1,351-1,329-43.98-51.292,617262.03
Upgrade
Net Income to Common
-1,351-1,329-43.98-51.292,617262.03
Upgrade
Net Income Growth
----898.92%83.54%
Upgrade
Shares Outstanding (Basic)
1,0241,0241,0281,0281,0271,028
Upgrade
Shares Outstanding (Diluted)
1,0241,0241,0281,0281,0271,028
Upgrade
Shares Change (YoY)
-0.54%-0.38%-0.02%0.04%-0.01%0.01%
Upgrade
EPS (Basic)
-1.32-1.30-0.04-0.052.550.26
Upgrade
EPS (Diluted)
-1.32-1.30-0.04-0.052.550.26
Upgrade
EPS Growth
----898.98%83.59%
Upgrade
Free Cash Flow
-746.75-448.3-365.39-64.49132.7937.98
Upgrade
Free Cash Flow Per Share
-0.73-0.44-0.36-0.060.130.04
Upgrade
Dividend Per Share
----2.8000.070
Upgrade
Dividend Growth
----3900.00%40.00%
Upgrade
Gross Margin
39.63%39.00%49.54%49.20%59.60%62.36%
Upgrade
Operating Margin
-20.93%-21.34%-2.74%-3.07%2.92%5.22%
Upgrade
Profit Margin
-46.25%-44.72%-1.21%-1.38%51.39%5.41%
Upgrade
Free Cash Flow Margin
-25.56%-15.09%-10.08%-1.73%2.61%0.78%
Upgrade
EBITDA
-504.97-526.2622.1511.49273.97419.42
Upgrade
EBITDA Margin
-17.29%-17.71%0.61%0.31%5.38%8.65%
Upgrade
D&A For EBITDA
106.58107.88121.68126.01125.13166.29
Upgrade
EBIT
-611.56-634.14-99.52-114.52148.84253.13
Upgrade
EBIT Margin
-20.93%-21.34%-2.74%-3.07%2.92%5.22%
Upgrade
Effective Tax Rate
----16.25%21.46%
Upgrade
Revenue as Reported
2,9212,9713,6263,7295,0944,848
Upgrade
Advertising Expenses
-1.09----
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.